Sai Life Sciences Limited — Updates, 06-08-2026: Press Release
06-08-2026 | 11:23 pm
06-08-2026 | 11:23 pm
Sai Life Sciences reported a strong Q1FY27: Revenue ₹554 Cr (+12% YoY), PAT ₹73 Cr (+22% YoY). CRO business grew 24%. A new 100,000 sq. ft. R&D facility operationalized. Strategic pharma engagements and strong CMC pipeline drive multi-year growth outlook.
No comments yet. Be the first to comment!
